Background: Large epidemiologic studies evaluating the etiologies, management decisions and outcomes of infants and children with meningitis and encephalitis in the United States are lacking. Methods: Children 0-17 years of age with meningitis or encephalitis as assessed by International Classification of Diseases, Ninth Revision, codes available in the Premier Healthcare Database during 2011-2014 were analyzed. Results: Six thousand six hundred sixty-five patients with meningitis or encephalitis were identified; 3030 (45.5%) were younger than 1 year of age, 295 (4.4%) were 1-2 years of age, 1460 (21.9%) were 3-9 years of age, and 1880 (28.2%) were 10-17 years of age. Etiologies included enterovirus (58.4%), unknown (23.7%), bacterial (13.0%), noninfectious (3.1%), herpes simplex virus (1.5%), other viruses (0.7%), arboviruses (0.5%) and fungal (0.04%). The majority of patients were male [3847 (57.7%)] and healthy [6094 (91.4%)] with no reported underlying conditions. Most underwent a lumbar puncture in the emergency department [5363 (80%)] and were admitted to the hospital [5363 (83.1%)]. Antibiotic therapy was frequent (92.2%) with children younger than 1 year of age with the highest rates (97.7%). Antiviral therapy was less common (31.1%). Only 539 (8.1%) of 6665 of patients received steroids. Early administration of adjunctive steroids was not associated with a reduction in mortality (P = 0.266). The overall median length of stay was 2 days. Overall mortality rate (0.5%) and readmission rates (<1%) was low for both groups. Conclusion: Meningitis and encephalitis in infants and children in the United States are more commonly caused by viruses and are treated empirically with antibiotic therapy and antiviral therapy in a significant proportion of cases. Adjunctive steroids are used infrequently and are not associated with a benefit in mortality.
T he prevalence of bacterial meningitis has drastically declined with the implementation of conjugate vaccines in the United States. 1 Meningitis and encephalitis in infants and children are now commonly caused by viruses as bacterial etiologies become less likely with the majority of them being admitted and receiving empirical antimicrobial therapy resulting in substantial costs. [2] [3] [4] Furthermore, the majority of patients continue to have unknown etiologies. Reasons for such high rates of diagnostic unknowns are likely because of combination of factors including noninfectious or unidentified causes. 5, 6 In some centers, contributing factors include underutilization of currently available diagnostic tests. 3, 4, 7 The use of adjunctive steroids in children with bacterial meningitis and encephalitis is primarily recommended for Haemophilus influenzae and possibly Streptococcus pneumoniae to prevent hearing loss and other neurologic sequelae, not mortality. 4, 8 In contrast, adjunctive steroids in adults are being used more frequently in pneumococcal meningitis primarily to impact mortality. 1, 9 The use of steroids among children is variable as the incidence of H. influenzae meningitis has dramatically decreased post vaccination. 2, 4, 9 Several large studies in children with viral meningitis, bacterial meningitis and encephalitis 2, 4, 8 have been done, but there are no large-scale epidemiologic studies evaluating all causes of meningitis and encephalitis in the pediatric population in the United States. The objective of our study was to compare the clinical epidemiology, management decisions and outcomes between infants and children with meningitis and encephalitis in the United States from 2011 to 2014.
MATERIALS AND METHODS

Study Population
Infants and children 0-17 years of age with an admitting and discharge diagnosis of meningitis or encephalitis as determined by International Classification of Diseases, Ninth Revision (ICD-9), diagnostic codes between January 1, 2011, and December 31, 2014, were eligible for the study. Only the first admission was included for analysis. Patients were excluded from the study if (1) the cerebrospinal fluid (CSF) was obtained 2 days before or after admission or emergency department visit (if not admitted), (2) they were electively admitted or had a trauma-related admission, (3) they have chronic meningitis, and (4) they have healthcare-associated ventriculitis or meningitis (CSF shunt, craniotomies, spinal procedures, or head trauma with CSF leaks during the 30 days before admission and at time of admission). We excluded children who underwent a lumbar puncture more than 2 days (1) before admission because of them having a low probability of meningitis or encephalitis and (2) after admission because of the increased likelihood of false-negative CSF cultures. All data were deidentified, and no individual data were reported in accordance to the Health Insurance Portability and Accountability Act.
Data Source
Data for the study were derived from the deidentified Premier Healthcare Database (PHD), the largest hospital discharge database in the United States. PHD currently contains data from >619 million patient encounters, or 1 in every 5 hospital discharges in the United States since January 2000 through June 2016. The PHD is a complete census of inpatient and hospital-based outpatient encounters from nearly 700 hospitals in all 50 states in the nation. Hospitals of all sizes, from large tertiary hospitals to small community hospitals in both rural and urban areas, are included in the database. PHD data includes patient demographics, admission and discharge diagnoses and dates, etiologies of meningitis and encephalitis, inpatient mortality, and discharge status. PHD also contains a date-stamped log of billed items, including procedures, medications, laboratory test results and diagnostic and therapeutic services at the individual patient level. All procedures and diagnoses are captured for each patient, as well as all drugs and devices received. Drug utilization information is available by day of stay and includes quantity, dosing, strength used and cost.
Frequency and duration of antibiotic, antiviral, antifungal and adjunctive intravenous steroid information was collected. Early adjunctive steroid therapy was defined as receipt of steroids on day 1 of antibiotic therapy.
Data Analysis
Descriptive data was summarized using frequencies and percentages for categorical variables and using median and interquartile range for each subgroup. χ 2 or Fisher exact tests were used to compare the differences among different age groups (younger than 1 year of age, 1-2 years of age, 3-9 years of age and 10-17 years of age). Two samples paired t tests were used for comparing differences in continuous variables. To adjust for multiple comparisons, we applied the Bonferroni correction, and we considered P < 0.001 to be statistically significant. All analyses were performed using SAS (version 9.4). 9
RESULTS
Cohort Assembly
A total of 6665 patients with an admitting or discharge diagnosis of meningitis or encephalitis were identified; 3030 (45.5%) were younger than 1 year of age, 295 (4.4%) were 1-2 years of age, 1460 (21.9%) were 3-9 years of age, and 1880 (28.2%) were 10-17 years of age.
Baseline Demographics, Comorbidities, Site of Care and Disposition
As seen in Table 1 , the majority were male [3847 (57.7%)], and the most common ethnicities included non-Hispanic white [2679 (40.2%)], Hispanic [1153 (17.3%)] and non-Hispanic black [972 (14.6%)]. The majority of patients were healthy [6094 (91.4%)] with no reported underlying conditions. The most common comorbidities were chronic pulmonary disease [401 (6.0%)] and cerebrovascular diseases [93 (1.4%)]. Human immunodeficiency virus infection/acquired immunodeficiency syndrome (AIDS) was seen in only 2 patients (0.03%). Chronic pulmonary diseases were higher in children than in infants younger than 1 year of age, and cerebrovascular disease was more common in infants and children from 1 to 2 years of age (P < 0.001). Patients were more likely to get a lumbar puncture in the emergency department [5,363 (80%) ] as opposed to in the hospital with infants being more likely admitted than children (P < 0.001). 
Frequency and Duration of Antibiotic, Antiviral and Antifungal Use
As shown in 
Utilization of Adjunctive Steroids
Only 539 (8.1%) of 6665 of patients received steroids as part of their admission treatment (see Table 2 ). Older children (10-17 years of age) had the highest rates [241 (12.8%)] of steroid use. The duration of steroid use was short (median 1-3 days) across all age groups. Steroids were most commonly used among patients with viral [227 (5.6%) of 4078], unknown [196 (12.7%) of 1546], and bacterial [97 (11.2%) of 869] etiologies. No difference was noted in mortality between children who received steroids and those who did not overall [2/304 (0.66%) vs. 33/6331 (0.52%); P value = 0.7) or by age group (see Table 2 ).
Length of Stay, Readmission Rates and Outcomes
The overall median length of stay was 2 days with longer stays noted among patients younger than 1 year of age (3 days) and 1-2 years of age (3 days; P < 0.001). The longest duration of stays was among children with bacterial meningitis [mean = 11.5 days (standard deviation = 10.4)], Herpes simplex virus [HSV; . The 30-day samecause readmission rate (0.72%) and mortality (0.53%) were low overall and not different between age groups. Patients with HSV, bacterial infections and arbovirus had highest readmission rates (HSV = 1.94%; bacterial = 1.96%; arbovirus = 2.78%) and mortality (HSV = 1.94%; bacterial = 1.84%; arbovirus = 2.78%).
Etiology
The majority of patients were admitted with enterovirus [n = 3892 (58.4%)] followed by unknown etiology [n = 1546 (23.2%)], bacteria [n = 869 (13.0%)] and HSV [n=103 (1.5%); Fig.  1 ]. Among age groups, children 1 to 2 years of age had the highest percentage of HSV [n = 9 (3.05%)] and unknown etiologies [n = 79 (26.8%)]. Arboviruses were only diagnosed among children older than 1 year of age (ie, 5 in children 1-2 years of age, 13 in children 3-9 years of age and 18 in children 10-17 years of age).
DISCUSSION
This is one of the largest studies to date (n = 6665) evaluating the epidemiology, management and outcomes of meningitis and encephalitis among infants and children in the United States using the largest hospital database in the United States. As seen in other studies, infants and children had high rates of hospitalization and empiric antimicrobial use. [2] [3] [4] Although the implementation of guidelines for the prevention of perinatal group B streptococcal invasive disease has been successful in reducing early-onset neonatal group B streptococcal diseases (sepsis), 10 the guidelines have not impacted late-onset disease (meningitis, bacteremia and arthritis). Meningitis due to group B streptococci and Escherichia coli remain the most common causes of bacterial meningitis in infants. 11 The majority of infants and children (92.2%) received intravenous antibiotic therapy while waiting for CSF cultures even though only a minority [869 (13.0%] had bacterial meningitis. Even though the bacterial meningitis score has excellent diagnostic accuracy to identify children at very low risk (0.1%), 12 it is most likely being underutilized in clinical practice and could account for this excessive use of antibiotics. 13 In addition, antivirals were commonly used (31.1%) with almost half of infants younger than 1 year of age (42.4%) receiving antivirals despite HSV being documented in only 1.75%. Enterovirus was the most common etiology seen (58.4%). Adults with meningitis and encephalitis in the United States receive empirical antiviral therapy more often (57%) with a median use of 3 days. 9 Empiric intravenous antifungal therapy was rarely used (1.3%) as only 3 patients had a fungal etiology. This is in sharp contrast to adults where 3%-7% of meningitis and encephalitis are caused by fungal etiologies. 9, 14 This is a large study documenting the use of adjunctive steroids in infants and children with all types of meningitis and encephalitis in the United States. Even though there is no mortality benefit seen in bacterial meningitis or viral encephalitis, 4,15 adjunctive steroids have been reported to be utilized in 44% of children with encephalitis in the United States. 8 Our study documented a lower overall proportion use of steroids (8.1%). Children (10-17 years of age) had the higher rates (12.8%). Among patients with viral etiologies, only 5.5% received steroids, which is a similar rate to prior reports. 2 In contrast, 12.7% of children with unknown etiologies were treated with steroids. This could possibly be explained by the treatment of suspected autoimmune encephalitis, a clear indication for empirical adjunctive steroids. 15, 16 Additionally, early use of adjunctive steroids (within the first day of antibiotic therapy) was not associated with a mortality benefit.
The overall median length of stay was 2 days and is consistent with the practice of awaiting CSF bacterial cultures. 2, 3, 9 The overall inpatient mortality and readmission rates for both infants and children were low (all <1%). As expected and similar to other studies, bacterial meningitis and HSV had longer duration of stay, higher inpatient mortality and readmission rates. 9, 17 Children with arboviral etiologies (n=36) also had a longer duration of stay (5.8 days), higher mortality (2.78%) and readmission rates (2.78%), most likely due to diagnostic bias, as encephalitis patients are more likely to be tested for West Nile Virus than those with meningitis. 7 Our study had several advantages. First, this is a large study comparing demographics, site of care, etiologies and outcomes in infants and children with meningitis or encephalitis in the United States. Furthermore, this is a large study describing the use of all types of antimicrobial therapies (antibiotics, antivirals and antifungals) and adjunctive steroids in children with meningitis and encephalitis. Despite these advantages, our study had several limitations. First, the etiologic diagnosis was based on ICD-9 diagnosis codes in hospital discharge data and was not corroborated with diagnostic tests potentially resulting in misclassification bias. Additionally, the use of ICD-9 codes also likely contributed to underreporting of noninfectious causes. Second, available clinical data were limited, and other factors that could impact mortality were not available and prevented us from performing multivariable analysis. Lastly, we were unable to perform a comparison between meningitis and encephalitis presentation caused by the same etiologies.
CONCLUSIONS
Meningitis and encephalitis among US children are commonly caused by viruses, and children are hospitalized and treated empirically with antibiotic and antiviral therapy. Adjunctive steroids are infrequently utilized and are not associated with a mortality benefit in any etiology. Earlier identification of the causative agents could in the future reduce unnecessary antimicrobial therapies for the majority of patients.
